Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Feasibility of the eLym™ System for the Decongestion of Excess Lymphatic Fluid Via the Thoracic Duct in Acute Decompensated Heart Failure

NCT05747196 is registered in ClinicalTrials.gov with WhiteSwell, Limited as lead sponsor.

NCT NCT05747196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05747196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Feasibility of the eLym™ System for the Decongestion of Excess Lymphatic Fluid Via the Thoracic Duct in Acute Decompensated Heart Failure
Lead sponsor
WhiteSwell, Limited
Phase
Not applicable
Overall status
Recruiting
Start date
February 28, 2023
Completion date
December 31, 2026
Enrollment
70 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

heart; decompensation, congestive